RAMPART: A phase III multi-arm multi-stage trial of adjuvant checkpoint inhibitors in patients with resected primary renal cell carcinoma (RCC) at high or intermediate risk of relapse. (2021)
Attributed to:
Method - Design
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.cct.2021.106482
PubMed Identifier: 34538402
Publication URI: http://europepmc.org/abstract/MED/34538402
Type: Journal Article/Review
Volume: 108
Parent Publication: Contemporary clinical trials
ISSN: 1551-7144